Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

The only known difference between M and L cones is the expression of opsin. Hadyniak’s team used colorimetric ... The team noted high expression of RA synthesis genes early in human retinal organoid ...

Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real ...

Biochemical Measurements of Free Opsin in Macular Degeneration Eyes: Examining the 11-CIS Retinal Deficiency Hypothesis of Delayed Dark Adaptation (An American Ophthalmological Society Thesis).

"A synthetic opsin restores vision in patients with severe retinal degeneration," in Molecular Therapy, the flagship journal of the American Society of Gene & Cell Therapy. The publication of ...